NASDAQ · ALXO
ALX Oncology Holdings Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ALXO: Nov 6, 2026
ALX Oncology Holdings Inc. Common Stock is estimated to report earnings on 11/06/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.14. The reported EPS for the same quarter last year was $-0.41.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.14 | $-0.13 | $-0.16 | 2 |
| Dec 2026 | $-0.15 | $-0.13 | $-0.17 | 2 |
| Mar 2027 | $-0.15 | $-0.13 | $-0.17 | 2 |
| Jun 2027 | $-0.17 | $-0.14 | $-0.19 | 2 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · MarketBeat · The Motley Fool · Fintel- Zacks · Aug 11, 9:40 AM EDTIs ALX Oncology Holdings (ALXO) Stock Outpacing Its Medical Peers This Year?Here is how ALX Oncology Holdings Inc. (ALXO) and Medpace (MEDP) have performed compared to their sector so far this year.
- Zacks · Jul 9, 1:34 PM EDTBIAF Stock Plunges 77% in 3 Months: Should You Still Hold or Sell?bioAffinity's CyPath Lung sales momentum is gaining traction, but wider losses, funding needs and regulatory risks keep pressure on the stock.
- MarketBeat · Jun 3, 11:02 PM EDTALX Oncology Targets Key Readouts to Advance CD47, EGFR Cancer Drug ProgramsALX Oncology (NASDAQ:ALXO) executives said the company is focused on advancing two clinical-stage oncology programs, with upcoming data readouts expected to shape potential later-stage development plans for its lead CD47 program, evorpacept, and its EGFR-targeted antibody-drug co
- The Motley Fool · Jun 1, 1:23 PM EDTALX Oncology (ALXO) Q1 2026 Earnings Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- Zacks · May 12, 9:40 AM EDTIs ALX Oncology Holdings (ALXO) Outperforming Other Medical Stocks This Year?Here is how ALX Oncology Holdings Inc. (ALXO) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.
- MarketBeat · May 8, 10:57 AM EDTALX Oncology Q1 Earnings Call HighlightsALX Oncology (NASDAQ:ALXO) executives used the company’s first-quarter 2026 earnings call to highlight new clinical data for its lead CD47 blocker, evorpacept, and to provide updates on its EGFR-targeted antibody-drug conjugate program, ALX2004. CEO Jason Lettmann said the quarte
- Zacks · Apr 16, 9:55 AM EDTbioAffinity Stock Surges 113.8% in 3 Months: What's Driving the Rally?BIAF is sharpening its focus on CyPath Lung, streamlining unprofitable services and pushing validation studies as it expands its lung-disease pipeline.
- Fintel · Mar 27, 1:46 PM EDTALX Oncology Holdings (ALXO) Price Target Increased by 38.00% to 4.69The average one-year price target for ALX Oncology Holdings (NasdaqGS:ALXO) has been revised to $4.69 / share. This is an increase of 38.00% from the prior estimate of $3.40 dated February 21, 2026. The price target is an average of many targets provided by an
- Fintel · Mar 19, 8:03 PM EDTWells Fargo Initiates Coverage of ALX Oncology Holdings (ALXO) with Overweight RecommendationFintel reports that on March 19, 2026, Wells Fargo initiated coverage of ALX Oncology Holdings (NasdaqGS:ALXO) with a Overweight recommendation. Analyst Price Forecast Suggests 55.96% Upside
- Zacks · Mar 18, 11:10 AM EDTALDX Crashes 71% as FDA Issues Third CRL for Dry Eye Disease Drug NDAAldeyra Therapeutics stock plunges 71% after the FDA issues a third CRL for the resubmitted reproxalap NDA for the treatment of dry eye disease.
- Zacks · Mar 17, 10:40 AM EDTCTMX Stock Rallies on Strong Phase I Colorectal Cancer Study DataCytomX Therapeutics stock surges 44% after phase I data for Varseta-M in heavily pretreated metastatic CRC show rising response rates and strong disease control.
- Zacks · Mar 16, 1:35 PM EDTIBRX Stock Jumps on Progress in NK Cell Therapy ProductionImmunityBio stock gains more than 7% after completing two programs, showing scalable production of M-ceNK NK cells and early safety data in solid tumor patients.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for ALX Oncology Holdings Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.